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The Bcl-2 family proteins plays a central role in apoptosis. The pro- or anti-apoptotic activities of
Bcl-2 family are dependent on the Bcl-2 homology (BH) regions. Bcl-rambo, a new pro-apoptotic
member, is unusual in that its pro-apoptotic activity is independent of its BH domains. However,
the mechanism underlying Bcl-rambo-induced apoptosis is largely unknown. Mitochondrial locali-
zation is indispensable for the pro-apoptotic function of Bcl-rambo. Bcl-rambo interacts physically
with the adenine nucleotide translocator (ANT), suppresses the ADT/ATP-dependent translocation
activity of ANT. Collectively, our data indicate Bcl-rambo is a pro-apoptotic member of the Bcl-2
family, induces the permeability transition via interaction with ANT.
Structured summary of protein interactions:
Bcl-Rambo and HSP60 colocalize by ﬂuorescence microscopy (View interaction)
Bcl-rambo binds to ANT1 by pull down (View interaction)
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction activity [7], and Bcl-XL prevents VDAC from forming large non-Bcl-2 family members are key protein regulators of cell death.
This family of proteins contains both pro-apoptotic and anti-apop-
totic members that decide the fates of cells at the mitochondrial
level [1,2]. Bcl-rambo is Bcl-2 protein family member with a
pro-apoptotic function [3,4]. However, unlike other Bcl-2 family
protein members, Bcl-rambo possesses a unique c-terminal exten-
sion (BHNo domain) with 2 repeated tandem domains A and B
(RTA and RTB) [3]. In addition, the conserved BH domains of
Bcl-rambo are not essential for triggering cell death [3], obscuring
the mechanism by which this protein causes cell death.
Mitochondria, and the mitochondrial permeability transition
(MPT) in particular, are known to play a central role in apoptotic
cell death [4,5]. The cause of the MPT is the opening of a non-
speciﬁc pore, known as the mitochondrial permeability transition
pore (PTP), which is a protein aggregate composed of Cyclophilin
D (Cyp-D), a voltage-dependent anion channel (VDAC), and the
adenine nucleotide translocator (ANT) [6]. Members of the Bcl-2
family of proteins interact with VDAC or ANT to regulate PT. For
examples, Bax and Bcl-2 physically bind to ANT to modulate itschemical Societies. Published by E
tor; BA, bonkrekic acid; BH,
ndrial membrane potential;
C, voltage-dependent anionspeciﬁc channels [8,9]. However, the precise molecular mecha-
nisms underlying the pro-apoptotic or anti-apoptotic activity of
Bcl-2 family proteins with regard to PTP regulation are largely un-
known. In this work, we report how Bcl-rambo facilitates apoptotic
cell death and identify signaling molecules involved in the MPT
using site-directed mutant plasmids and recombinant proteins.
2. Materials and methods
2.1. Cells and reagents
PC-3 prostatic cancer cells, purchased from the American Type
Culture Collection (Rockville, MD), were cultured in RPMI 1640
medium. Anti-VDAC and -ANT antibodies were obtained from
Calbiochem (La Jolla, CA). Anti-Cyclophilin D and anti-V5 antibod-
ies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA)
and Invitrogen (Carlsbad, CA), respectively. Cyclosporin A (CsA)
and bonkrekic acid (BA) were obtained from Calbiochem. Mitotrac-
ker was from Molecular Probes, Inc. (Eugene, OR). All other
chemicals or reagents were obtained from Sigma–Aldrich (St.
Louis, MO) unless otherwise speciﬁed.
2.2. Cloning and plasmid construction
DNA encoding Bcl-2 or Bcl-rambo cloned into pcDNA3.1/V5
(Invitrogen, Carlsbad, CA). Deletion mutants of Bcl-rambo orlsevier B.V. All rights reserved.
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method as described previously [10].
2.3. Apoptosis detection and caspase-3 assay
After DAPI (1 lg/ml in PBS) staining, apoptotic cells with frag-
mented nuclei or chromatin condensation were counted manually
under a immunoﬂuorescence microscope. Caspase-3 activity was
measured using the Colorimetric Caspase-3 Assay Kit (Calbiochem,
CA) as described previously [11]. Absorbance at 405 nm was deter-
mined 6 h after initiation of the reaction.
2.4. Transfection, immunoprecipitation and immunoblotting
PC-3 cells (3  105/10 cm culture dish) were transiently trans-
fected with 2 lg of each plasmid using Lipofectamine 2000 (Invit-Fig. 1. The TM domain of Bcl-rambo is crucial for induction of apoptotic cell death. (A) S
transfectedwithwild-typeBcl-ramboormutant plasmids for48 h.Apoptotic cell deathwasm
mock-transfected cells was arbitrarily set to 1. (D) Expression levels of V5-tagged pcDNA-Brogen). For immunoprecipitation, cells were lysed in ice cold NP40
lysis buffer [50 mM Tris/HCl (pH 8.0), 150 mM NaCl, 1% NP-40 and
complete protease inhibitor cocktail], incubated with the indicated
antibodies, and immunoprecipitated with protein A (Sigma–Al-
drich). The precipitates were washed four times, subjected to
SDS–PAGE, and analyzed by western blotting.
2.5. Puriﬁcation of recombinant proteins
Bcl-rambo, Bcl-ramboDTM, Rambo-Bcl2-TM, Rambo-BNip3-TM,
and Rambo-Cyb5-TM cDNA were subcloned into the pGEX-2TK
vector (Amersham Pharmacia Biotechnology, NJ) tagged with glu-
tathione S-transferase (GST). Bound GST-fusion proteins were
eluted by thrombin protease treatment. The amount of puriﬁed
recombinant protein was estimated by the Biuret method.chematic representation of Bcl-rambo deletion mutants. PC-3 cells were transiently
easuredbyDAPI staining (B) and caspase-3 activity assay (C). Thecaspase-3 activity of
cl-rambo plasmids determined by performing western blot with anti-V5 antibody.
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PC-3 cells were ﬁxed with 4% paraformaldehyde in PBS and per-
meabilized with 0.1% Triton X-100. The cells were incubated with
primary antibody for 2 h at room temperature, and then stained
with secondary antibody conjugated with FITC or Texas-Red and
viewed using a confocal microscope (META 510, Zeiss, Germany).
2.7. Mitochondrial preparation and determination of the PT
Mitochondria were freshly isolated from the liver of a 1-month-
old rat by differential centrifugation as described previously [12].
Mitochondrial swelling was monitored by measuring the spectro-
photometric refractory index at 540 nm at 10 min intervals. To
assess mitochondrial membrane potential, PC-3 cells were
incubated with 400 nm MitoTracker Red CMXRos (Molecular
Probes Inc.). The ﬂuorescent intensity was measured by ﬂowFig. 2. Mitochondrial localization of Bcl-rambo is crucial for its pro-apoptotic activity. (A
24 h, cells were double-stained with anti-V5 (FITC) and anti-HSP60 (Texas Red) antibodie
indicated mutants for 48 h. Apoptotic cell death was measured by DAPI staining (B)
determined by performing western blot with anti-V5 antibody.cytometry (FACScaliver, Beckton Dickinson, CA) using the
CellQuest program.
2.8. Adenine nucleotide transport assay
The effect of Bcl-rambo on ADP transport was determined as de-
scribed previously [13]. Mitochondria (1 mg/ml) were pre-treated
with various concentrations of recombinant Bcl-rambo in assay
buffer for 10 min, and then further incubated with 20 lM [14C]
ADP for 20 s at 0 C. The radioactivity of the mitochondrial lysate
was determined using a liquid scintillation counter (Wallac 1409,
Perkin-Elmer).
Liposomes were prepared by solubilization of 400 mg of
phosphatidylcholine, 400 mg of phosphatidylserine, and 230 mg
cholesterol in PBS, pH 7.2, as described previously [14,15]. Puriﬁed
ANT protein were mixed with the liposome and then loaded with
ATP. Unincorporated ATP was removed by chromatography on) Cells were transiently transfected with Bcl-rambo or the indicated mutants. After
s. (B and C) PC-3 cells were transiently transfected with wild-type Bcl-rambo or the
and caspase-3 activity assay (C) as described in Methods. (D) Expression levels
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temperature with 100 lM ADP and puriﬁed Bcl-rambo recombi-
nant proteins or GST control protein were added. Analysied for
the released ATP in the supernatant was quantiﬁed by a lucifer-
ine-luciferase assay as described in Ref. [16].
3. Results
3.1. The TM domain of Bcl-rambo is crucial for its pro-apoptotic
activity
Unlike the other Bcl-2 family proteins, Bcl-rambo contains a
unique BHNo domain with 2 repeated tandem domains, RTA and
RTB [3], as well as conserved BH domains and carboxyl-terminal
membrane anchor domain (TM). To understand the contribution
of the BH, BHNo, and TM domains of Bcl-rambo in its proapoptoticFig. 3. Bcl-rambo induces loss of MMP through a BA-sensitive pathway. (A) Cells were tr
were incubated with MitoTracker Red at 2-h intervals. Fluorescent intensity was measure
c release from mitochondria was determined in transfected cells (top) and puriﬁed mit
transfected cells, by differential centrifugation, or isolated mitochondria (1 mg protein/
veriﬁed by western blotting using anti-HSP60 and anti-Tubulin antibodies to detect m
transfected with Bcl-rambo in the presence or absence of speciﬁc inhibitors such as C
transfection, alterations in the MMPwere determined with MitoTracker Red. After the cel
(D).activity, we constructed deletion mutant plasmids (Fig. 1A). After
48 h of transient transfection with wild-type or mutant constructs,
cell death rates were determined by DAPI staining and caspase-3
activity assay. Deletion of the BH1, BH2, BH3, or BH4 domains,
and RTA, or RTB did not affect the pro-apoptotic activity of Bcl-
rambo (Fig. 1B). However, consistent with a previous report [3],
deletion of the TM domain abolished the protein’s death-inducing
property (Fig. 1, B, and C), indicating that the TM domain plays a
pivotal role in the cell death pathway.
3.2. Mitochondrial localization is crucial for the pro-apoptotic activity
of Bcl-rambo
The TM domain of Bcl-rambo probably is essential for mito-
chondrial targeting and pro-apoptotic activity [3]. This raises the
question of whether the unique sequence identity of the TMansiently transfected with mock or Bcl-rambo. After 10 h of transfection, PC-3 cells
d by ﬂow cytometry. Bax and BNip3 were used as reference controls. (B) Cytochrome
ochondria (bottom). Mitochondrial and cytosolic fractions were prepared from the
ml) were incubated with puriﬁed Bcl-rambo (1 lg/ml). Purity of the fractions was
itochondrial and cytosolic proteins, respectively. (C) PC-3 cells were transiently
sA and BA or co-transfected with pcDNA-Bcl-2. After 24 h of transfection or co-
ls were treated as described in (C), cell death rates were determined by DAPI staining
Fig. 4. Bcl-rambo induces permeability transition in isolated mitochondria. (A)
Isolated mitochondria (1 mg protein/ml) suspended in respiration buffer were
incubated with 1 lg of the recombinant Bcl-rambo proteins for various time
intervals. Mitochondrial swelling indicative of PT induction was assessed by
measuring the optical density (OD) at 540 nm. (B) Isolated mitochondria were
incubated with the recombinant Bcl-rambo proteins and CsA, BA, or Bcl-2 proteins
at the indicated time intervals. OD was measured at 540 nm.
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pro-apoptotic activity of Bcl-rambo. To analyze this, we
constructed chimeric mutant plasmids by deleting TM domain of
Bcl-rambo (Bcl-ramboDTM) or mutants with the TM domain re-
placed with heterologous TM domain sequences from Bcl-2 (Ram-
bo-Bcl2-TM), BNip3 (Rambo-BNip3-TM), or rat cytochrome b5
(Rambo-Cyb5-TM). We transiently transfected PC-3 cells with
wild-type Bcl-rambo or chimeric mutant plasmids. The staining
patterns obtained for Bcl-rambo, Rambo-Bcl2-TM, and Rambo-
BNip3-TM resembled the punctuate mitochondrial distribution of
heat shock protein 60 (HSP60) (Fig. 2A) [17]. Rambo-Cyb5-TM
and Bcl-ramboDTM showed a globular or diffuse staining pattern
(Fig. 2A). To determine whether Bcl-rambo mutants targeted to
mitochondrial or non-mitochondrial sites were able to promote
cell death, we determined the cell death rates with DAPI staining
(Fig. 2B) and caspase-3 assay (Fig. 2C) after 48 h of transfection.
Cell death rates were signiﬁcantly increased in cells transfected
with Bcl-rambo, Rambo-Bcl2-TM, or Rambo-BNip3-TM. In contrast,
transfection with Rambo-Cyb5-TM and Bcl-ramboDTM did not
increase the cell death rates. These data indicate that the pro-apop-
totic activity of Bcl-rambo depends on mitochondrial localization,
but not on the unique amino acid sequence of the TM domain.
3.3. Bcl-rambo induces the loss of mitochondrial membrane potential
Because mitochondrial localization is crucial for the pro-apop-
totic activity of Bcl-rambo, we investigated whether Bcl-rambo in-
duces the loss of mitochondrial membrane potential (MMP, DWm).
After 10 h of transfection with Bcl-rambo or the mock control,
MMP was determined at 2-h intervals with MitoTracker Red. De-
crease in MMP was observed 12 h after transfection of the cells
with Bcl-rambo, whereas no decrease was observed in the mock-
transfected cells (Fig. 3A). Bax and BNip3 are known to induce
MMP loss; thus, Bax and BNip3 were used as a positive control
for determining MMP loss. Cytochrome c was translocated into
the cytosol by Bcl-rambo and mitochondria-targeted molecules,
Rambo-Bcl2-TM and Rambo-BNip3-TM. (Fig. 3B), suggesting that
mitochondrial damage occurs during Bcl-rambo-induced cell
death. To further characterize the pathways by which Bcl-rambo
induced mitochondrial damage, we transiently transfected PC-3
cells with Bcl-rambo in the presence or absence of speciﬁc PT
inhibitors such as CsA and BA, or co-transfected the cells with
pcDNA-Bcl-2. BA inhibits ANT and CsA attach to CyP-D, and there-
by prevents their interaction with other PTP components and effec-
tively blocks PT [18]. BA suppressed Bcl-rambo-induced membrane
perturbation (Fig. 3C), whereas, CsA did not block MMP loss. Bcl-2
overexpression partly inhibited MMP loss. Consistent with the
MMP alterations, BA protected against Bcl-rambo-induced apopto-
tic cell death, whereas CsA failed to inhibit Bcl-rambo-induced
apoptotic cell death. Bcl-2 overexpression did not rescue cells from
apoptosis (Fig. 3C and D). Our data indicate that Bcl-rambo facili-
tates cell death by inducing BA-sensitive MMP loss.
3.4. Bcl-rambo induces PT in isolated mitochondria
MPT plays a central role in apoptotic cell death [4,5]. MPT is
caused by the opening of PTP, which supposedly leads to the
MMP loss and cytochrome c release.
To conﬁrm our results and identify what other components are
involved in PT induction, we tested whether recombinant Bcl-ram-
bo (rBcl-rambo) or its chimeric mutants were able to dissipate
MMP in isolated mitochondria. We incubated freshly isolated
mitochondria from rat liver with 1 lg of puriﬁed rBcl-rambo,
rRamboDTM, rRambo-BNip3-TM, rRambo-Bcl2-TM, or rRambo-
Cyb5-TM in respiration buffer, and assessed mitochondrial swell-ing indicative of PT induction by measuring the optical density at
540 nm. In agreement with the in vivo data, the mitochondria were
swollen in the presence of rBcl-rambo, rRambo-BNip3-TM, or
rRambo-Bcl2-TM, but not in the presence of rRamboDTM or rRam-
bo-Cyb5-TM (Fig. 4A). Mitochondrial swelling was suppressed by
the PT inhibitor BA, but not by CsA or rBcl-2 (Fig. 4B). These
in vitro data indicate that Bcl-rambo directly induces PT through
a BA-sensitive pathway.
3.5. Bcl-rambo interacts with adenine nucleotide translocator to
induce PT
The in vivo and in vitro data suggest that Bcl-rambo inducesMMP
loss through a BA-sensitive pathway.We therefore investigated the
interactions between Bcl-rambo and the components of PTP. Pro-
teins extracted from PC-3 cells transfected with Bcl-rambo were
immunoprecipitated with anti-V5 antibody and then blotted with
anti-ANT, anti-VDAC, or anti-Cyp-D antibody. ANT co-precipitated
with Bcl-rambo, whereas VDAC or Cyp-D did not (Fig. 5A). We then
investigated whether the physical interaction between Bcl-rambo
andANT is crucial for cell death. PC-3 cellswere transiently transfec-
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immunoprecipitated with anti-V5 antibody and blotted with
anti-ANT antibody. Rambo-Bcl2-TM and Rambo-BNip3-TM, both
of which induce cell death, were co-precipitatedwith ANT, whereas
Rambo-Cyb5-TM and Bcl-ramboDTM, neither of which induces cell
death,werenot co-precipitatedwithANT (Fig. 5B). Interaction studyFig. 5. Bcl-rambo interacts physically with the ANT. (A) Cells were transfected with mock
controls. After 24 h of transfection, cell lysates were immunoprecipitated with anti-V5 an
anti-V5 antibodies. A 10% loading control is shown in the lower panel (Input). (B) Cells
immunoprecipitation assay was performed with anti-V5 antibody to determine the spe
determine whether Bcl-rambo-ANT binding is direct, we performed a GST pull-down assa
(D) Co-localization study. Cells were double-stained with anti-V5 (FITC) and anti-ANT (Te
ANT2 (siANT1, siANT2) or scrambled siRNA (siSCR). ANT knockdown was assessed by p
measured with DAPI staining (bottom).with puriﬁed Bcl-rambomutants and puriﬁed ANT in GST full-down
assay and co-localization study by confocalmicroscopy showed that
Bcl-rambo directly interacts with ANT (Fig. 5C and D).
To further demonstrate the effect of ANT in Bcl-rambo-induced
cell death, we transfected the cells with siRNA targeting ANT1 and
ANT2 (siANT1, siANT2) or scrambled siRNA (siSCR) to downregu-or V5-tagged Bcl-rambo expression plasmid. Bax and BNip3 were used as reference
tibody and western blotting was performed with anti-ANT, anti-VDAC, anti-Cyp-D or
were transfected with mock and V5-tagged mutant plasmids as indicated, and an
ciﬁcity of the interaction between Bcl-rambo and ANT in transfected cells. (C) To
y with GST-tagged Bcl-rambo mutants and recombinant ANT puriﬁed from bacteria.
xas Red) antibodies. (E) PC-3 cells were transfected with siRNA targeted to ANT1 and
erforming western blot with an anti-ANT antibody (top), and cell death rate was
3148 J.-Y. Kim et al. / FEBS Letters 586 (2012) 3142–3149late endogenous ANT expression; immunoblotting conﬁrmed that
the expression of ANT was signiﬁcantly reduced by more than
80% in the PC-3 cells (Fig. 5E). After a 48-h transfection of ANT-
knockdown cells with Bcl-rambo wild-type and mutants (Fig. 5E),
Bcl-rambo-induced cell death reduced. These data indicate that
ANT is crucial for Bcl-rambo induced cell death.
3.6. Bcl-rambo reduces adenine nucleotide transport in isolated
mitochondria
To determine whether Bcl-rambo affects ANT activity, we
investigated the effects of Bcl-rambo and its chimeric mutants on
mitochondrial [14C]ADP transport. Isolated mitochondria were
incubated with 20 lM [14C]ADP in the presence of rBcl-rambo,
rBcl-RamboDTM, rRambo-Bcl2-TM, rRambo-BNip3-TM, or rRam-
bo-Cyb5-TM. rBcl-rambo, rRambo-Bcl2-TM, and rRambo-BNip3-
TM signiﬁcantly inhibited ADP uptake (P < 0.05), whereas
rRambo-Cyb5-TM or rBcl-ramboDTM did not (Fig. 6A). To show
that the decrease in ADP uptake was not due to Bcl-rambo-induced
mitochondrial swelling/dysfunction, we assessed ANT activity in
liposomes by analyzing the released ATP in the supernatant. The
ADP-induced release of ATP was signiﬁcantly inhibited by Bcl-ram-
bo, suggesting that ADP uptake is not due to Bcl-rambo-induced
mitochondrial swelling/dysfunction (Fig. 6B).Fig. 6. Bcl-rambo suppresses ADP/ATP translocation. (A) Isolated mitochondria
from rat liver were incubated with 20 lM [14C] ADP in the presence of the indicated
recombinant proteins. The reaction was terminated by the addition of 100 lM
atractyloside, and incorporated radioisotope-labeled ADP was measured with a
liquid scintillation counter. Bcl-rambo, Rambo-Bcl2-TM, and Rambo-BNip3-TM
signiﬁcantly inhibited ADP uptake (P < 0.05). Bax and BNip3 were used as reference
controls. (B) ANT activity was performed in liposomes as described in Methods. The
ADP-induced release of ATP was quantiﬁed by a luciferine-luciferase assay.4. Discussion
Bcl-2 family proteins can be subdivided into pro-apoptotic or
anti-apoptotic members on the basis of their ability to induce or
inhibit cell death, respectively [19]. Bcl-rambo is a pro-apoptotic
member of the Bcl-2 family of proteins. Although the TM domain
is known to be important for the optimal activity of Bcl-rambo,
the molecular mechanisms of Bcl-rambo-induced cell death
remain largely unknown. We initially characterized which do-
mains of Bcl-rambo are essential for its pro-apoptotic activity,
using deletion mutants (Fig. 1A). Deletion of the BH domain, RTA,
or RTB did not signiﬁcantly affect Bcl-rambo’s cell-killing activity,
suggesting that these domains participate in other biological func-
tions such as signal transduction. Consistent with a previous report
[3], deletion of the TM domain abolished the pro-apoptotic ability
(Fig. 1B and C). These results indicate 2 possibilities: First, mito-
chondrial localization per se is essential for the activity of this
protein. If this were the case, substitution of the TM domain of
Bcl-rambo with the TM domain of other members that efﬁciently
target molecules to mitochondria would yield chimeric proteins
with cell-killing ability. Second, mitochondrial localization is
important, but not essential, for the optimal activity of these pro-
teins. For example, substitution of the TM domain of BNip3 with
the corresponding sequence of cytochrome b5, which targets
BNip3 to non-mitochondrial sites, diminished the proapoptotic
activity of BNip3 to half that of wild-type BNip3 [10]. This suggests
that BNip3 activates different pathways for cell-death induction
other than the mitochondrial pathway. To date, Bcl-rambo and
BNip3 have several cell death pathway characteristics in common.
First, both of them induce BH3-independent cell death [20].
Second, the TM domains of Bcl-rambo and BNip3 are crucial for
their pro-apoptotic activity, as shown by other researchers and
us previously [21,22]. In addition, substitution of the TM domain
of Bcl-rambo or BNip3 with the corresponding domain of Bcl-2
does not affect the pro-apoptotic activity of Bcl2-rambo or BNip3.
However, there probably are differences in the cell death pathways
activated by Bcl-rambo and BNip3: for instance, targeting of Bcl-
rambo to non-mitochondrial sites resulted in a loss of its pro-apop-
totic activity, whereas this was not true for BNip3 [10]. Therefore,
we propose that mitochondrial localization, rather than a uniqueTM domain sequence, is essential for the pro-apoptotic activity of
Bcl-rambo, which is consistent with our ﬁndings on the involve-
ment of MMP loss in Bcl-rambo-induced cell death (Fig. 3).
Although the detailed mechanisms of PT induction remains contro-
versial, pro-apoptotic or anti-apoptotic Bcl-2 family proteins
regulate PT by interacting with the component(s) of the PTP [23].
Our ﬁnding that Bcl-rambo induced a BA-inhibitable PT led us to
identify critical proteins involved in the Bcl-rambo-induced PT.
We performed immunoprecipitation to understand the interaction
between the components of PTP and Bcl-rambo. We found that Bcl-
rambo interacts with ANT to induce PT. In addition, the mitochon-
dria-targeted molecules, Rambo-Bcl2-TM and Rambo-BNip3-TM,
interact with ANT, whereas the non-mitochondria-targeted pro-
teins, Rambo-Cyb5-TM and Rambo-DTM, do not. These results
strongly suggest that cell death signaling by Bcl-rambo is linked
to ANT. Our results suggest that the TM domain is not responsible
for the interaction with ANT because, as shown Fig. 5A, wild-type
BNip3 didn’t interact with ANT, suggesting TM domain is only
responsible for only mitochondrial localization. ANT catalyzes the
import of cytosolic ADP and the export of matrix ATP [24]. Our
results led us to study the effects of Bcl-rambo on the ADP translo-
cation ability of ANT. Recombinant Bcl-rambo, Rambo-Bcl2-TM,
and Rambo-BNip3-TM suppressed ADP/ATP translocation of ANT,
whereas Rambo-DTM and Rambo-Cyb5-TM (non-mitochondrial
proteins) failed to suppress the ADP/ATP translocation of ANT.
J.-Y. Kim et al. / FEBS Letters 586 (2012) 3142–3149 3149Collectively, our data demonstrated that Bcl-rambo interacts
with the PTP composite protein ANT to induce the loss of MMP,
resulting in caspase activation and apoptotic cell death.
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